Showing results (1481-1490 of 2,777) with videos related to
Sort By:
Pageof 278
Clinical and Experimental Nephrology|January 7, 2020
Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunctionYusuke Uemura, Shinji Ishikawa, Kenji Takemoto, et al.Clinical and Experimental Nephrology|March 13, 2020
Kidney function, blood pressure and proteinuria were associated with pregnancy outcomes of pregnant women with chronic kidney disease: a single-center, retrospective study in the Asian populationSatoshi Kumakura, Koji Okamoto, Saeko Takeuchi, et al.Clinical and Experimental Nephrology|December 4, 2019
Preventive effect of early introduction of everolimus and reduced-exposure tacrolimus on renal interstitial fibrosis in de novo living-donor renal transplant recipientsHiroaki Ishida, Go Ogura, Saeko Uehara, et al.Clinical and Experimental Nephrology|December 4, 2019
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 studyTatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.Clinical and Experimental Nephrology|January 20, 2019
Identification of new urinary risk markers for urinary stones using a logistic model and multinomial logit modelAtsushi Okada, Ryosuke Ando, Kazumi Taguchi, et al.Clinical and Experimental Nephrology|November 12, 2020
The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational studyYoko Obata, Takahiro Takazono, Masato Tashiro, et al.Clinical and Experimental Nephrology|March 7, 2018
Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD)Shiho Makabe, Toshio Mochizuki, Michihiro Mitobe, et al.Clinical and Experimental Nephrology|March 15, 2018
Rationale, design, and characteristics of a trial to evaluate the new phosphate iron-based binder sucroferric oxyhydroxide in dialysis patients with the goal of advancing the practice of E.B.M. (EPISODE)Yoshitaka Isaka, Hideki Fujii, Yoshihiro Tsujimoto, et al.Clinical and Experimental Nephrology|December 21, 2013
Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathyTakashige Kuwabara, Kiyoshi Mori, Masashi Mukoyama, et al.Clinical and Experimental Nephrology|November 1, 2013
Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiencyShuma Hirashio, Toshinori Ueno, Takayuki Naito, et al.Pageof 278